PRAME and cervical cancer: Consistent with these findings, PRAME, HMGA2, SBK1, MEX3A, TM7SF2, SLC19A1, ETV4, PYCR1, and TTYH3 showed higher expression in HPV-negative cervical cancer tissues than in HPV-positive and normal cervical tissues.